Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meter Health is a private biotechnology and healthtech company focused on clinically significant hiccups, including occasional, chronic, and cancer-associated hiccups. The company markets Hiccupops, a patented consumer product designed for occasional hiccup relief, and is also advancing research and development programs intended to produce next-generation, potentially FDA-approved treatments for more severe hiccup conditions. Meter Health positions itself as a science-driven company built around a narrowly defined but underserved medical problem with both consumer and prescription-treatment potential. Its leadership team includes executives with prior experience at major biopharma companies and the company highlights collaborations spanning clinical practice and academic research. Overall, Meter Health is best understood as a niche symptoms-focused biotech developing hiccup-specific products and therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meter.